Prevalence and clinical correlates of JAK2 mutations in Down syndrome acute lymphoblastic leukemia

Recurrent, prognostically significant chromosomal abnormalities occur in approximately 75% of pediatric acute lymphoblastic leukemia (ALL), but only infrequently in children with Down syndrome (DS) and ALL. Recently, novel somatic activating mutations in Janus kinase 2 (JAK2) were reported in 18% of...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Gaikwad, Amos, Rye, Cassia L., Devidas, Meenakshi, Heerema, Nyla A., Carroll, Andrew J., Izraeli, Shai, Plon, Sharon E., Basso, Giuseppe, Pession, Andrea, Rabin, Karen R.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2008
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2724897/
https://ncbi.nlm.nih.gov/pubmed/19120350
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2141.2008.07552.x
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller